Found vs Willow: Personalized biology vs structured progress tracking
Found vs Willow compares two telehealth weight management programs with different emphases. Early verdict: Found centers on a biology-first, personalized medically supervised program with affordable monthly plans starting at $39, while Willow emphasizes an oral GLP-1 experience built around progress tracking and follow-up with a higher entry price point (299).
How they differ at a glance
Found and Willow both deliver telehealth weight-management services, but their distinguishing features are clear: Found focuses on individualized biology-based plans and broad insurance handling, while Willow focuses on structured digital follow-up and progress tracking tied to oral GLP-1 treatment.
Distinctive differences we will compare
- Approach to care: biology-first personalization vs structured progress tracking
- Medication types and regulatory notes: compounded options and FDA disclaimers
- Pricing and insurance handling
- Follow-up and clinical oversight
Direct comparison table
| Criteria | Found | Willow |
|---|---|---|
| Starting price | $39 (get started for as low as $39) | 299 |
| Care approach | Biology-first personalized medically supervised program | Structured journey with progress tracking and follow-up |
| Medication types | Tirzepatide; Semaglutide; Compounded options noted | Oral GLP-1 (program centered on oral medication) |
| Insurance | Most insurance now accepted; Found handles insurance paperwork | Not supplied on captured page |
| Follow-up | Personalized program including metabolic and lifestyle targeting | Licensed telehealth team with follow-up consultations and tracking tools |
| Regulatory note | Compounded GLP-1s are not FDA-approved and are not reviewed by FDA for safety, effectiveness or quality | Compounded medications, when offered, are not FDA-approved and are not reviewed by FDA for safety, effectiveness or quality |
Approach to care: personalization versus structured support
Found builds programs around each patient’s metabolic biology, including hormones, blood sugar regulation, sleep, and behavior. Willow positions its oral GLP-1 program as a structured weight management journey that emphasizes progress tracking and follow-up support to convert medication effects into sustainable outcomes. Both are telehealth-first but the emphasis differs: Found on individualized biology and holistic whole-body factors; Willow on behavioral scaffolding and digital follow-up.
Medication options and regulatory notes
Found lists medications including tirzepatide and semaglutide and explicitly notes compounded GLP-1s; Found states compounded GLP-1s are not FDA-approved or evaluated for safety or efficacy and are not available in all states. Willow emphasizes oral GLP-1 delivery and notes that compounded medications, when offered, are not FDA-approved and are not reviewed by FDA for safety, effectiveness or quality. Both providers state that prescriptions are subject to clinician review or medical appropriateness where supplied.
Pricing and insurance handling
Found advertises affordable monthly plans and getting started for as low as $39, and it states most insurance is now accepted and that it handles insurance paperwork. Found also provides specific program and membership pricing notes and mentions advertised pricing with commitments and Medicare Bridge program details where captured. Willow’s captured evidence shows a 299 starting price but captured landing-page evidence was not readable for additional pricing or shipping details.
Follow-up, clinical oversight, and who they suit
Found emphasizes a medically supervised program that targets hormones, metabolism, sleep, and lifestyle and notes results vary by individual. Willow highlights licensed telehealth teams, follow-up consultations, and progress tracking tools for users who want structured digital follow-up rather than medication-only approaches. Where supply limitations exist, Willow’s captured page lacked more detailed shipping or membership terms.
Conclusion: Found vs Willow
Found vs Willow comes down to priorities. If you want a biology-first, personalized medically supervised program with lower advertised starting prices and explicit insurance handling, Found is presented as the option for that approach. If you prefer an oral GLP-1 pathway embedded in a structured program with progress tracking and follow-up support, Willow emphasizes that model. Both note clinician review and regulatory limits around compounded medications.
Choose Found if…
you want a biology-first, personalized medically supervised program with affordable monthly plans starting as low as $39 and explicit insurance paperwork handling.
Choose Willow if…
you want an oral GLP-1 program that emphasizes progress tracking and follow-up consultations through a licensed telehealth team.
Ready to Compare Telehealth Providers?
Explore leading providers — physician-supervised, all-inclusive pricing, and free home delivery.
Compare All Providers →More comparisons
